
Dyania Health has been accepted into the 2025 CancerX Accelerator Program, joining a select cohort of health and AI startups dedicated to addressing critical gaps in oncology.
Jersey City, New Jersey (Feb. 18, 2025) – Dyania Health has been accepted into the 2025 CancerX Accelerator Program. Dyania was selected as a startup that addresses real-world gaps in cancer care.
CancerX is a public-private partnership designed to accelerate innovation in the fight against cancer. The 2025 Accelerator cohort features health and artificial intelligence startups dedicated to addressing critical challenges in oncology. This year’s cohort will focus on improving cancer care by improving access to treatment, accelerating clinical trials, and providing personalized, connected care for patients beyond the clinic.
The CancerX Accelerator is a flagship program for CancerX, designed to match unmet needs within Champion organizations with suitable innovations from startups in the field. Startups can be championed by one or more organizations and are offered a range of support, from mentorship and product feedback to conducting pilots and signing commercial agreements. The 4-month program also provides startups with a weekly educational curriculum covering four tracks: working with health systems, working with industry, working with the public sector, and a speaker series on scaling their business within oncology.
“We are honored to join CancerX and collaborate with industry leaders dedicated to transforming cancer care,” said Eirini Schlosser, CEO and Founder of Dyania Health. “Closing critical gaps in oncology demands innovation, partnership, and a deep understanding of both patient and provider needs. Our solutions align with CancerX’s mission to accelerate clinical research, and we are eager to work alongside leading experts to drive meaningful advancements and improve outcomes for cancer patients worldwide.”
About CancerX
CancerX is a groundbreaking public-private partnership designed to accelerate innovation in the fight against cancer. Hosted by the Moffitt Cancer Center, in collaboration with the Office of the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), CancerX is part of the InnovationX program launched in 2018. To learn more about the CancerX accelerator or this year’s cohort, please visit www.cancerx.health/accelerator.